STOCK TITAN

Freshpet CEO sells 39K shares after option exercise

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freshpet, Inc. (FRPT) reported that Chief Executive Officer and director William B. Cyr and related family entities exercised options and sold shares on August 26, 2026. In total, 76,001 options with a $10.23 exercise price were exercised into common stock and 39,664 shares of common stock were sold. Cyr directly sold 37,007 shares at a weighted average price of about $74.67, while his spouse and related trusts sold additional shares at prices around $75.40. The filing states these sales were effected under a Rule 10b5-1 trading plan adopted on November 5, 2025. The options were granted under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.

Positive

  • None.

Negative

  • None.
Insider Cyr William B.
Role Chief Executive Officer
Sold 39,664 shs ($2.96M)
Approx. gross sale proceeds $2.96M
Approx. exercise cost $777K
Type Security Shares Price Value
Exercise Options to purchase common stock F1, F5 56,442 $0.00 $0.00
Exercise Options to purchase common stock F5 4,180 $0.00 $0.00
Exercise Options to purchase common stock F5 8,170 $0.00 $0.00
Exercise Options to purchase common stock F5 7,209 $0.00 $0.00
Exercise Common Stock F1 56,442 $10.23 $577K
Sale Common Stock F2, F3, F4, F1 37,007 $74.67 $2.76M
Exercise Common Stock 4,180 $10.23 $43K
Sale Common Stock F2 568 $75.40 $43K
Exercise Common Stock 8,170 $10.23 $84K
Sale Common Stock F2 1,110 $75.40 $84K
Exercise Common Stock 7,209 $10.23 $74K
Sale Common Stock F2 979 $75.40 $74K
Holdings After Transaction: Options to purchase common stock — 0 shares (Direct); Options to purchase common stock — 0 shares (Indirect, By Spouse); Options to purchase common stock — 0 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Options to purchase common stock — 0 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants); Common Stock — 350,744 shares (Direct); Common Stock — 49,044 shares (Indirect, By Spouse); Common Stock — 106,530 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Common Stock — 96,677 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants)
Footnotes (5)
  1. F1. The amount reported reflects a de minimis adjustment of one (1) share due to rounding.
  2. F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
  3. F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.6671 to $74.6674.
  4. F4. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
  5. F5. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
Options exercised 76,001 shares Total derivative exercises (code M) on August 26, 2026
Shares sold 39,664 shares Total net shares sold reported in the Form 4
Option exercise price $10.23 per share Exercise price for options to purchase Freshpet common stock
Weighted average sale price about $74.67 per share 37,007 shares sold by William B. Cyr in multiple transactions
Additional sale price $75.40 per share Sales by spouse and related trusts on August 26, 2026
Rule 10b5-1 plan adoption date November 5, 2025 Date the CEO adopted the trading plan used for these sales
Vesting date of options December 31, 2020 Options were fully vested as of this date
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Omnibus Incentive Plan financial
"The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan."
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

What did Freshpet (FRPT) CEO William B. Cyr report in this Form 4?

William B. Cyr reported exercising 76,001 options at an exercise price of $10.23 per share and the sale of 39,664 common shares on August 26, 2026, including transactions by his spouse and related trusts.

How many Freshpet (FRPT) shares were sold in total in this Form 4?

The filing reports total sales of 39,664 shares of Freshpet common stock on August 26, 2026, combining sales by William B. Cyr, his spouse, and related trusts.

At what prices were the Freshpet (FRPT) shares sold in Cyr’s Form 4?

Direct sales of 37,007 shares by William B. Cyr occurred at a weighted average price of about $74.67 per share, with a range of $74.6671 to $74.6674. Additional sales by related entities occurred at $75.40 per share.

What options did the Freshpet (FRPT) CEO exercise in this Form 4?

The CEO and related entities exercised options covering 76,001 shares of Freshpet common stock at an exercise price of $10.23 per share. These options were issued under the 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.

Were the Freshpet (FRPT) stock sales by William B. Cyr under a Rule 10b5-1 plan?

Yes. The filing states that the sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by William B. Cyr on November 5, 2025, and the Form 4’s Rule 10b5-1 checkbox is marked as affirmed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cyr William B.

(Last)(First)(Middle)
C/O FRESHPET, INC.
1450 US-206

(Street)
BEDMINSTER NEW JERSEY 07921

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/26/2026M56,442(1)A$10.23387,751(1)D
Common Stock08/26/2026S(2)37,007D$74.67(3)(4)350,744(1)D
Common Stock08/26/2026M4,180A$10.2349,612IBy Spouse
Common Stock08/26/2026S(2)568D$75.449,044IBy Spouse
Common Stock08/26/2026M8,170A$10.23107,640IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/26/2026S(2)1,110D$75.4106,530IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/26/2026M7,209A$10.2397,656IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock08/26/2026S(2)979D$75.496,677IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options to purchase common stock$10.2308/26/2026M56,442(1) (5)09/06/2026Common Stock56,442(1)$00D
Options to purchase common stock$10.2308/26/2026M4,180 (5)09/06/2026Common Stock4,180$00IBy Spouse
Options to purchase common stock$10.2308/26/2026M8,170 (5)09/06/2026Common Stock8,170$00IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2308/26/2026M7,209 (5)09/06/2026Common Stock7,209$00IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Explanation of Responses:
1. The amount reported reflects a de minimis adjustment of one (1) share due to rounding.
2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.6671 to $74.6674.
4. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
5. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
/s/ Andrew Lampert, as attorney-in-fact for the Reporting Person08/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)